CARVIDON

This brand name is authorized in Nigeria.

Active ingredients

The drug CARVIDON contains one active pharmaceutical ingredient (API):

1	Trimetazidine UNII 48V6723Z1P - TRIMETAZIDINE DIHYDROCHLORIDE
	In patients with ischaemic heart disease, trimetazidine acts as a metabolic agent, preserving the myocardial high-energy phosphate intracellular levels.
	Read more about Trimetazidine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4286	Tablet	CARVIDON-MR TABLETS TAB 35 mg 3x10	CARVIDON-MR TABLETS TRIMETAZIDINE HYDROCHLORIDE The fellowing are the excipients: 1. Hypromellose (Methocel K4M) 2. Hypromellose (Methocel K100 LV) 3. Lactose (Pharmatose DCL 15) 4. Croscarmellose Sodium (Primellose) 5. Talc 6. Magnesium Stearate 7. Colloidal Anhydrous silica (Aerosil200) 8. Hypromellose (HPMC 15cps) 9. Isopropyl Alcohol 10. Dichloromethane (Methylene Chloride) 11.Polysorbate 80 (Tween 80) 1Propylene Glycol2. Titanium Dioxide 13. Iron Oxide Red 14. Propylene Glycol B4-4286 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 22/04/2021 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com MICRO LABS LIMITED -UNIT III, R.S. NO. 63/3 & 4, THIRUVANDAR KOIL, PONDICHERRY 605 102, INDIA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01EB15	Trimetazidine	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4286